Salesforce (CRM)
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-09-04
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-09-04
QuarterlyIQ Insights · CRM
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $259 CRM trades at 16× p/e, below its 27× p/e peer median, but our blended $227 fair value sits below the price. We hold it with medium confidence: the peer anchor overstates how cheap it looks. Analysts target $200–$325. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $270.50 | — | — | Analyst | high |
| dcf fcff | 12M | $1337.28 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $41.84 | — | — | TTM | high |
| graham number | 12M | $129.28 | — | — | TTM | high |
| Peer EV/EBITDA |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$200.00 – $325.00 (median $270.50) · 10 analysts · as of 2026-09-02
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2026-Q2, 2026-Q3, 2027-Q1, 2027-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| 12M |
| $175.08 |
| 13.6 |
| 15.61 |
| TTM |
| high |
| Peer P/FCF | 12M | $331.69 | 18.6 | 17.86 | TTM | high |
| Peer P/E | 12M | $283.87 | 17.5 | 16.24 | ntm analyst | high |
| Peer P/S | 12M | $201.77 | 3.8 | 53.52 | TTM | high |
| residual income | 12M | $99.51 | — | — | TTM | high |
| Own P/E history | 12M | $240.19 | 15.1 | 15.89 | TTM | high |
| triangulated | 12M | $448.76 | 27.4 | 16.35 | Triangulated | high |
| Peer P/FCF | 3Y | $504.46 | 18.6 | 27.16 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $311.82 | 17.5 | 17.84 | Analyst | medium |
| Peer P/S | 3Y | $252.31 | 3.8 | 66.92 | guidance | medium |
| Own P/E history | 3Y | $262.81 | 15.1 | 17.39 | Analyst | medium |
| Peer P/FCF | 5Y | $667.15 | 18.6 | 35.92 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $342.52 | 17.5 | 19.60 | Analyst | high |
| Peer P/S | 5Y | $277.14 | 3.8 | 73.51 | guidance | high |
| Own P/E history | 5Y | $288.68 | 15.1 | 19.10 | Analyst | high |